Search

You searched for "laser surgery"

154 results found

RSM Laryngology & Rhinology: the year ahead

4 November 2022
As the president of the RSM’s Laryngology & Rhinology Section for the 2022-23 academic year, my aim is to centre the education programme around our trainees, with a real emphasis on inspiring the future generation of ENT surgeons.

British Skull Base Society Clinical Consensus Document on Management of Head and Neck Paragangliomas (HNPGLs)

7 January 2021 | | Head and Neck, Skull Base Surgery | paraganglioma, radiotherapy, surgery, treatment
All forms of HNPGLs should be managed by a multidisciplinary team (MDT) of core members from skull base otolaryngology, head and neck surgery, clinical genetics, oncology, endocrinology, vascular surgery, radiology and pathology. Extended members include neurosurgery, endocrine surgery, nuclear medicine,...

The Otolaryngology, Head and Neck Surgery session at the 2019 RCSI (Royal College of Surgeons in Ireland) Charter Day

8 February 2019
Collaboration- How can we help? Report by: Nash Patil- ENT Consultant/Sligo, Michael Fitzsimmons- CST Trainee/Dublin. Collaboration was the theme of the Otolaryngology, Head and Neck Surgery session at this year’s Royal College of Surgeons in Ireland (RCSI) Charter Day held...

Across the pond: a tale of two fellowships

1 September 2016 | | ENT
Where in the world is Halifax? Many outside of Canada have never heard of the Maritime Canadian town of Halifax. Before leaving to start a year-long fellowship there, we both had to answer many questions from family and friends about...

VACANCY: Consultant Otolaryngologist, Wellington, New Zealand

25 October 2023 | Recruitment & Personnel
Location: Wellington Regional Hospital, Kenepuru Hospital and Hutt Hospital

The future of rhinology: What will come first, a radical change in rhinological management or the decimation of the world?

1 March 2019 | | ENT, Rhinology / Sinus, Rhinoplasty
In this article, Simon Gane looks forward to what the future holds, on the presumption he survives. Setting aside the questions of the UK even existing, the NHS still working, or the fact we’ll be commuting to our jobs in...

Hearing rehabilitation after vestibular schwannoma surgery

27 February 2020 | | ENT, Otology, Vestibular Disorders
Hearing rehabilitation is a key focus of the management of patients with vestibular schwannoma. But how do we rehabilitate hearing when the cochlear nerve has been damaged by tumour, irradiation, or resective surgery? Mathieu Trudel, Scott Rutherford and Simon Lloyd...

History of innovation in ENT

2 November 2020 | | ENT, Laryngology / Swallowing / Voice, Otology, Rhinology / Sinus
Innovation seems to have been in the strapline of every meeting, conference and course for the last few years. You would be forgiven for thinking it is a new a concept, but as Neil Weir beautifully details, innovation has been...

Accolade for hearing-loss experts

28 February 2024
The ARO Pioneer Award in Basic Science for 2024 has been given to Dr Andrej Kral and Dr Stephen G Lomber in recognition of their fundamental work on understanding brain plasticity after hearing loss.

What’s happened since the European position paper on nose and sinus tumours?

1 May 2017 | | ENT, Rhinology / Sinus
The management of malignant sinonasal tumours has gone through radical changes in recent years. Prof Valerie Lund gives us an update based on her upcoming talk at IFOS. In 2010 when we published the European position paper on ‘endoscopic management...

Anaesthesia for excision of vestibular schwannomas

27 February 2020 | | ENT, Otology
The ‘shared airway’ relationship between ENT surgeons and anaesthetists is well documented. But ENT surgery and anaesthesia interact in numerous other ways, particularly in complex skull base surgery. What do our anaesthetic colleagues want us to know about vestibular schwannoma...

The changing spectrum of cancer of the oropharynx: dilemmas and future directions

1 March 2016 | | ENT, Laryngology / Swallowing / Voice, Head and Neck
The association of HPV in oropharyngeal cancer has identified a ‘new disease’, with its unique biologic behaviour, and challenges for clinicians in selecting therapeutic combinations offering maximum efficacy and minimum morbidity or long-term sequela currently under study in clinical trials....